The Clinical Effect of Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis: Single Arm Open-label Trial
Latest Information Update: 04 Feb 2025
Price :
$35 *
At a glance
- Drugs Levofloxacin (Primary)
- Indications Cutaneous leishmaniasis
- Focus Therapeutic Use
- 04 Feb 2025 New trial record